The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Logynon Tablets

Bayer LimitedPA1410/005/001

Main Information

Trade NameLogynon Tablets
Active SubstancesLevonorgestrel micronized
Levonorgestrel micronized
Levonorgestrel micronized
Ethinylestradiol micronized
Ethinylestradiol micronized
Dosage FormCoated tablet
Licence HolderBayer Limited
Licence NumberPA1410/005/001

Group Information

ATC CodeG03AB Progestogens and estrogens, sequential preparations
G03AB03 levonorgestrel and ethinylestradiol


License statusAuthorised
Licence Issued26/08/1981
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceNone
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back